|1.||Hagiya, Hideharu: 2 articles (01/2015 - 01/2014)|
|2.||Otsuka, Fumio: 2 articles (01/2015 - 01/2014)|
|3.||Sendo, Toshiaki: 1 article (01/2015)|
|4.||Tasaka, Ken: 1 article (01/2015)|
|5.||Terasaka, Tomohiro: 1 article (01/2014)|
|6.||Kondo, Eisei: 1 article (01/2014)|
|7.||Ogawa, Hiroko: 1 article (01/2014)|
|8.||Shimamura, Yasunori: 1 article (01/2014)|
|9.||Waseda, Koichi: 1 article (01/2014)|
|10.||Horita, Masahiro: 1 article (01/2014)|
07/01/1983 - "Plasma clearance was 76.8 +/- 8.2 ml/min. Moxalactam was found to be highly effective in the therapy of life-threatening infections."
11/01/1981 - "Except for some severe P aeruginosa infections outside the urinary tract, moxalactam is effective and safe single-agent therapy for infections caused by susceptible organisms and represents a major advancement in beta-lactam antimicrobial therapy."
04/01/1982 - "We concluded that moxalactam was effective in the treatment of the types of infections included in this study and produced few adverse reactions."
02/01/1989 - "It is concluded that a single dose of moxalactam is as effective as a 48-hour course when attempting to prevent infection after contaminated abdominal surgery."
02/01/1985 - "Latamoxef appears to be an effective antibiotic for the treatment of neutropenic patients with infection."
11/01/1982 - "Fourteen of 18 isolates from cerebrospinal fluid were susceptible to less than or equal to 0.5 micrograms of moxalactam/ml. Cerebrospinal fluid concentrations of moxalactam in four patients were 2.4-16 micrograms/ml. This accumulated experience indicates that moxalactam has been effective in the treatment of patients with meningitis due to highly susceptible enteric gram-negative bacilli. "
04/01/1981 - "It remains to be further determined whether 6059-S is superior to ABPC in the treatment of Haemophilus influenzae meningitis."
05/01/1982 - "Moxalactam appears to be an effective antibiotic for the treatment of neonatal gram-negative bacillary meningitis."
09/01/1981 - "In this small series, moxalactam, when administered intravenously as the sole agent of therapy, was effective in the treatment of meningitis caused by susceptible gram-negative bacilli."
11/01/1983 - "Moxalactam appears to be safe and effective as primary therapy for meningitis caused by H influenzae or N meningitidis."
|3.||Wounds and Injuries (Trauma)
10/01/1983 - "Moxalactam concentrations in wound fluid exceeded serum concentrations and the usual minimum inhibitory concentration of the infecting organism. "
11/01/1983 - "The single adverse clinical reaction noted was the development of a wound hematoma in a postoperative patient; this problem may have been related to moxalactam therapy. "
03/01/1986 - "A randomized controlled clinical trial was undertaken in 542 consecutive emergency and elective abdominal operations, with one group of patients receiving tetracycline peritoneal and wound lavage and the other a single intravenous injection of 1 g latamoxef at induction of anaesthesia. "
10/01/1982 - "Of 30 patients with predominantly anaerobic localized infections superimposed on chronic tissue damage related to trauma, ischemia, or tumor, 22 (73%) responded satisfactorily to moxalactam therapy. "
02/01/1986 - "Moxalactam is as effective as combination (clindamycin and tobramycin) antimicrobial therapy in patients with penetrating abdominal trauma."
|4.||Bacterial Infections (Bacterial Infection)
03/01/1982 - "Early clinical experience indicates that moxalactam is effective for the treatment of a number of bacterial infections, including those involving the abdominal cavity and respiratory and urinary tracts. "
05/01/1981 - "6059-S was effective in 17 cases out of 18 cases with bacterial infections. "
04/01/1981 - "From the present study, 6059-S appears to be a safe and effective antibiotic when used in children with susceptible bacterial infections. "
01/01/1983 - "Lamoxactam seems to be an effective and safe single-agent therapy for many bacterial infections. "
06/01/1982 - "The mean elimination half-life was 91.2 min. These data indicate that this dosage of moxalactam is a safe and effective treatment for bacterial infections outside the central nervous system."
08/01/1983 - "Moxalactam pharmacokinetics at steady state was examined in a group of 40 patients with presumed or proven abdominal sepsis. "
01/01/1983 - "[Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia]."
01/01/1982 - "Sixty patients including forty two males and eighteen females, age range: 18-87 years, received antibacterial single drug treatment with latamoxef for septicemia. "
01/01/1982 - "[Treatment of septicemia with latamoxef. "
08/04/1981 - "In 31 patients (88.6%) the therapy was successful, in 2 patients no evaluation was possible and in 2 patients the therapy was unsuccessful, including one patient with a primarily moxalactam-resistant Bacteroides fragilis responsible for sepsis. "
|4.||Cefoxitin (Cefoxitin Sodium)
|6.||Cefoperazone (Cefoperazone Sodium)
|1.||Drug Therapy (Chemotherapy)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)